Vanguard Group
GH icon

Vanguard Group’s Guardant Health GH Stock Holding History

Vanguard Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.24B Buy
12,160,768
+251,939
+2% +$22.5M 0.02% 633
2025
Q3 		$744M Sell
11,908,829
-259,191
-2% -$14.1M 0.01% 836
2025
Q2 		$633M Buy
12,168,020
+86,643
+0.7% +$3.87M 0.01% 899
2025
Q1 		$515M Buy
12,081,377
+28,826
+0.2% +$1.24M 0.01% 975
2024
Q4 		$368M Buy
12,052,551
+350,606
+3% +$9.86M 0.01% 1221
2024
Q3 		$268M Buy
11,701,945
+65,213
+0.6% +$1.85M ﹤0.01% 1383
2024
Q2 		$336M Buy
11,636,732
+200,706
+2% +$4.67M 0.01% 1202
2024
Q1 		$236M Buy
11,436,026
+305,372
+3% +$6.55M ﹤0.01% 1409
2023
Q4 		$301M Buy
11,130,654
+180,424
+2% +$4.73M 0.01% 1287
2023
Q3 		$325M Buy
10,950,230
+146,902
+1% +$5.17M 0.01% 1162
2023
Q2 		$387M Buy
10,803,328
+1,569,545
+17% +$45.1M 0.01% 1084
2023
Q1 		$216M Buy
9,233,783
+193,543
+2% +$5.53M 0.01% 1408
2022
Q4 		$246M Buy
9,040,240
+124,674
+1% +$5.7M 0.01% 1324
2022
Q3 		$480M Buy
8,915,566
+74,247
+0.8% +$3.81M 0.01% 859
2022
Q2 		$357M Buy
8,841,319
+90,319
+1% +$4.48M 0.01% 1064
2022
Q1 		$580M Sell
8,751,000
-11,086
-0.1% -$759K 0.01% 875
2021
Q4 		$876M Buy
8,762,086
+57,156
+0.7% +$5.91M 0.02% 713
2021
Q3 		$1.09B Buy
8,704,930
+77,430
+0.9% +$9.2M 0.03% 607
2021
Q2 		$1.07B Buy
8,627,500
+486,607
+6% +$65.5M 0.03% 629
2021
Q1 		$1.24B Buy
8,140,893
+519,656
+7% +$78.5M 0.03% 546
2020
Q4 		$982M Buy
7,621,237
+1,094,241
+17% +$126M 0.03% 593
2020
Q3 		$730M Buy
6,526,996
+207,731
+3% +$19M 0.02% 626
2020
Q2 		$513M Buy
6,319,265
+2,144,771
+51% +$173M 0.02% 751
2020
Q1 		$291M Buy
4,174,494
+107,362
+3% +$8.24M 0.01% 911
2019
Q4 		$318M Buy
4,067,132
+711,112
+21% +$51.2M 0.01% 1093
2019
Q3 		$214M Buy
3,356,020
+462,200
+16% +$40.7M 0.01% 1292
2019
Q2 		$250M Buy
2,893,820
+1,741,472
+151% +$133M 0.01% 1219
2019
Q1 		$88.4M Buy
1,152,348
+18,893
+2% +$1.05M ﹤0.01% 1812
2018
Q4 		$42.6M Buy
+1,133,455
New +$41.8M ﹤0.01% 2111

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group's GH Position: Q4 2025 in Review

Vanguard Group increased its Guardant Health (GH) stake by 2.1% in Q4 2025, buying an estimated $22.5M and bringing the position to 12,160,768 shares worth $1.24B. The position accounts for 0.02% of the portfolio, ranked #633.

Vanguard Group first reported a position in GH in Q4 2018 and has held it in 29 quarters since. The position peaked at $1.24B in Q1 2021. 495 funds tracked by Wall St. Rank hold GH as of Q4 2025.

  • Vanguard Group held 12,160,768 shares of Guardant Health worth $1.24B as of Q4 2025.
  • Vanguard Group bought 251,939 Guardant Health shares in Q4 2025, an estimated $22.5M.
  • Guardant Health made up 0.02% of Vanguard Group's portfolio in Q4 2025, its #633 holding.
  • Vanguard Group first reported a position in Guardant Health in Q4 2018 and has held it in 29 quarters since.
  • Vanguard Group's Guardant Health position peaked at $1.24B in Q1 2021.
  • 495 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.